Brief: Immuneering Reports First Quarter 2022 Financial Results And Recent Business Highlights

Immuneering

10/05/2022 11:35

May 10 (Reuters) - Immuneering Corp  IMRX.O :
    * IMMUNEERING REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
    * IND FILING FOR IMM-1-104 EXPECTED IN Q3 2022; ENROLLMENT
OF
FIRST PATIENT EXPECTED IN Q4 2022
    * Q1 LOSS PER SHARE $0.49
    * REITERATES FULL YEAR GAAP OPERATING EXPENSES TO BE BETWEEN
$55.0
MILLION AND $60.0 MILLION
    * Q1 EARNINGS PER SHARE VIEW $-0.45 -- REFINITIV IBES DATA
    * QTRLY REVENUE  $183,698 VERSUS $748,200

Source text for Eikon:  ID:nGNX5Wp2k5 
Further company coverage:  IMRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))